Nanocarrier-based gene delivery for immune cell engineering-Reference-Cited by-同舟云学术

Nanocarrier-based gene delivery for immune cell engineering

Published:2024 Issue:14 Volume:12 Page:3356-3375
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Gharatape Alireza¹,Sadeghi-Abandansari Hamid²^ORCID,Seifalian Alexander³^ORCID,Faridi-Majidi Reza¹,Basiri Mohsen⁴⁵^ORCID

Affiliation:

1. Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

2. Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Tehran, Iran

3. Nanotechnology & Regenerative Medicine Commercialisation Centre (NanoRegMed Ltd, Nanoloom Ltd, & Liberum Health Ltd), London BioScience Innovation Centre, London, UK

4. Department of Stem Cells and Developmental Biology and Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Tehran, Iran

5. T Cell Therapeutics Research Labs, Cellular Immunotherapy Center, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA 91010, USA

Abstract

Nanocarriers hold great potential for engineering immune cells based on their performance (efficiency, safety and specificity). This review focuses on different stages of the transfection process and some important challenges.

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/TB/D3TB02279J

Reference222 articles.

1. Monoclonal antibodies: versatile platforms for cancer immunotherapy

2. Biomaterials for vaccine-based cancer immunotherapy

3. Engineering Dendritic Cells to Enhance Cancer Immunotherapy

4. The Principles of Engineering Immune Cells to Treat Cancer

5. T-Cell Engineering for Cancer Immunotherapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in nucleic acid delivery strategies for diabetic wound therapy;Journal of Clinical & Translational Endocrinology;2024-09

2. Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment;eBioMedicine;2024-08